| Literature DB >> 19894263 |
Guohua Li1, Advait Badkar, Haripriya Kalluri, Ajay K Banga.
Abstract
The objective of this study was to investigate the feasibility of using microneedle technology to enhance transcutaneous permeation of human immunoglobulin G (IgG) across hairless rat skin. Microchannels created by maltose and metal (DermaRoller) microneedles were characterized by techniques such as methylene blue staining, histological examination, and calcein imaging. Methylene blue staining and histological sections of treated skin showed that maltose microneedles and DermaRoller breached the skin barrier by creating microchannels in the skin with an average depth of approximately 150 microm, as imaged by confocal microscopy. Calcein imaging and pore permeability index values suggested the uniformity of the created pores in microneedle-treated skin. Transdermal studies with IgG indicated a flux rate of 45.96 ng/cm(2)/h, in vitro, and a C(max) of 7.27 ng/mL, in vivo, for maltose microneedles-treated skin while a flux rate of 353.17 ng/cm(2)/h, in vitro, and a C(max) of 9.33 ng/mL, in vivo, was achieved for DermaRoller-treated skin. Transepidermal water loss measurements and methylene blue staining, in vivo, indicated the presence of microchannels for upto 24 h, when occluded. In conclusion, the microchannels created by maltose microneedles and DermaRoller resulted in the percutaneous enhancement of a macromolecule, human IgG. 2009 Wiley-Liss, Inc. and the American Pharmacists AssociationEntities:
Mesh:
Substances:
Year: 2010 PMID: 19894263 DOI: 10.1002/jps.21981
Source DB: PubMed Journal: J Pharm Sci ISSN: 0022-3549 Impact factor: 3.534